Redefining the ambulatory prescription business.
As outcomes management becomes more sophisticated and more widespread, the practice of managed care will be altered. Similarly, the ambulatory prescription business will be redefined to fit the needs of this environment. Potentially, the new definition could expand the ambulatory prescription business to encompass responsibility for the outcomes of the drug use process: clinical, quality-of-life, and cost outcomes. A redefinition of the business requires that issues be addressed with respect to accountability and financing.
Larson
L N
LN
D000553:Ambulatory Care; D010593:Pharmaceutical Services; D014481:United States